Company news
Liquidia Corporation news in 2022
Liquidia Corporation's news releases, calls and decks from 2022, newest first.
Liquidia Announces Collaboration to Develop a New Infusion Pump for Subcutaneous Delivery of Treprostinil Injection to Treat Pulmonary Arterial Hypertension (PAH)
December 4, 2022
Liquidia Reports Third Quarter 2022 Financial Results and Provides Corporate Update
November 7, 2022
Liquidia to Report Third Quarter 2022 Financial Results on November 8, 2022
October 31, 2022
Precedential Opinion Panel Denies United Therapeutics’ Request for Review of ‘793 Inter Partes Review Decision
October 26, 2022
Liquidia Announces Presentations at the CHEST 2022 Annual Meeting
October 16, 2022
Liquidia Provides Update on Hatch-Waxman Litigation and to Host Call on September 1, 2022, at 8: 00am E.T.
August 30, 2022
Liquidia Reports Second Quarter 2022 Financial Results and Provides Corporate Update
August 10, 2022
Liquidia to Report Second Quarter 2022 Financial Results on August 11, 2022
August 3, 2022
Liquidia to Participate in Upcoming Investor Conferences
July 31, 2022
Liquidia Announces the Publication of Long-Term Clinical Data from Completed INSPIRE Study in the Journal Pulmonary Circulation
July 31, 2022
Liquidia Corporation Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
July 20, 2022
Liquidia Receives Favorable Ruling in Inter Partes Review against United Therapeutics Patent
July 18, 2022
Liquidia Corporation Added to Russell 2000® and 3000® Indexes
June 26, 2022
Liquidia Appoints Rajeev Saggar, M.D., as Chief Medical Officer
June 19, 2022
Liquidia Announces Presentation at the 2022 Pulmonary Hypertension Association (PHA) International Conference
June 8, 2022
Update to Liquidia’s Participation in the Jefferies Healthcare Conference
June 6, 2022
Liquidia to Participate in the Jefferies Healthcare Conference
June 1, 2022
Liquidia Announces Presentations at the 2022 American Thoracic Society (ATS) International Conference
May 15, 2022
Liquidia Reports First Quarter 2022 Financial Results and Provides Corporate Update
May 11, 2022
Liquidia to Report First Quarter 2022 Financial Results on May 12, 2022
May 4, 2022
Liquidia Announces Oral Presentation at the 42nd Annual Meeting of International Society for Heart and Lung Transplant (ISHLT)
April 19, 2022
Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option
April 17, 2022
Liquidia Announces Proposed Offering of Common Stock
April 11, 2022
Liquidia Corporation Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
March 21, 2022
Liquidia Corporation Reports Full-Year 2021 Financial Results and Provides Corporate Update
March 16, 2022
Liquidia Corporation to Report Full Year 2021 Financial Results on Thursday, March 17, 2022
March 9, 2022
Liquidia Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 22, 2022
Liquidia Re-Finances Debt Facility With Silicon Valley Bank To Increase To $40.0 Million
January 6, 2022
Liquidia Corporation Announces Chief Executive Officer Transition
January 2, 2022